Key result
Minimal intermittent heparin administration based on APTT monitoring was safe during hemodialysis, with 0 hemorrhages or clotting problems observed in high-risk patients.
Why the study?
Does minimal intermittent heparin administration prevent hemorrhages and clotting problems in patients undergoing hemodialysis?
Observational
Does minimal intermittent heparin administration prevent hemorrhages and clotting problems in patients undergoing hemodialysis?
Minimal intermittent heparin administration monitored by APTT appears safe and effective for preventing clotting without causing hemorrhage during hemodialysis, even in high-risk postoperative and polytrauma patients.
Answers are grounded in this paper and cite their sources.
May support APTT-guided minimal heparin in high-risk hemodialysis; hypothesis-generating and requires randomized confirmation.
Anticoagulation with comparatively small amounts of heparin has been carried out in more than 3,000 acute and chronic hemodialysis procedures without problems. In a selected high risk group of postoperative and polytrauma patients no patient hemorrhages have occurred, nor have there been any clotting problems in the dialyser circuit. Studies to elucidate the underlying mechanisms of coagulation and anticoagulation in the extracorporeal environment have been performed. Minimal intermittent heparin administration based on plastic anticoagulation monitoring with the APTT method, has proven to be particularly safe.
No takes yet. Share an insight, caveat, or question.
Vogel et al. (1978) conducted an observational in Acute and chronic hemodialysis. Minimal intermittent heparin administration was evaluated on Hemorrhages and clotting problems. Minimal intermittent heparin administration based on APTT monitoring was safe during hemodialysis, with 0 hemorrhages or clotting problems observed in high-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: